NCT03823651

Brief Summary

The purpose of this study is to evaluate the feasibility and outcomes of a research pre- and peri-transplant optimization program (R-PPOP) to improve multiple domains of health including physical function, cognitive function, mental health, and diet and nutrition for patients planning to undergo or undergoing hematopoietic stem cell transplantation (HCT).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
29

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started May 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 28, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 30, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

May 6, 2019

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 27, 2022

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 27, 2024

Completed
5 months until next milestone

Results Posted

Study results publicly available

September 27, 2024

Completed
Last Updated

September 27, 2024

Status Verified

September 1, 2024

Enrollment Period

3.5 years

First QC Date

January 28, 2019

Results QC Date

October 10, 2023

Last Update Submit

September 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Who Completed at Least Half of Their High Intensity Interval Training Sessions

    Participants were asked to record or report their exercise sessions.

    6 months

Other Outcomes (31)

  • Measuring Changes in the Skin Flora (Microbiome) in Caregivers

    baseline, sign off, day 0 (transplant), 7, 14, 21, 30, 60, 90,180, 365

  • Changes in Fecal Samples as Measured by 16s rRNA Sequencing in Caregivers

    baseline, sign off, day 0 (transplant), 7, 14, 21, 30, 60, 90,180, 365

  • Caregiver Quality of Life as Assessed by the Caregiver Strain Questionnaire

    1 year

  • +28 more other outcomes

Study Arms (2)

Patient

EXPERIMENTAL

These are patients undergoing hematopoetic stem cell transplant. Patients will complete Interval training, undergo psychiatric consult, nutrition/diet evaluation and referral to social worker.

Behavioral: Interval trainingBehavioral: Psychiatric consultBehavioral: Nutrition/diet evaluationBehavioral: Referral to Social Worker

Caregiver

EXPERIMENTAL

These are the assigned caregivers for transplant patients. Caregivers will undergo psychiatric consult, nutrition/diet evaluation and referral to social worker.

Behavioral: Psychiatric consultBehavioral: Nutrition/diet evaluationBehavioral: Referral to Social Worker

Interventions

Patients will be asked to complete up to 3 x 30-minute structured high intensity interval training aerobic exercise sessions/week. For the first session, patients will come to the Duke Center for Living for in person evaluation and training. After the initial training session in person, a subsequent training session will take place at the patient's home via iPad/iPhone videoconference using a device provided to the patient to provide additional support and the opportunity to answer questions. Subsequent sessions will be done independently by patients, but study staff will be available via iPad/iPhone if questions arise.

Patient

Subjects who score below threshold on the PHQ2/PHQ9, PC-PTSD/PCL-5, PROMIS-Depression and/or PROMIS-Anxiety assessments will be referred to a psychiatrist for follow up.

CaregiverPatient

PG-SGA, ASA24, food group tracking Assessments and Vit D, Vit A, albumin, prealbumin, lipids, A1c levels will be used to provide weekly feedback for one month

CaregiverPatient

Subjects who score below threshold on the PROMIS-Emotional Support and/or PROMIS-Social Isolation assessments will be referred to a social worker for follow up

CaregiverPatient

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Plan to undergo an allogeneic hematopoietic stem cell transplant for any cancer or non-cancer illness within the next 6 months
  • Age 18-80 years

You may not qualify if:

  • Both patient and caregiver are unable to read and follow directions in English (ok if only patient cannot read and follow directions in English as caregiver will be able to help).
  • Any absolute contraindications to exercise:
  • recent (\< 6 months) acute cardiac event;
  • unstable angina;
  • uncontrolled dysrhythmias causing symptoms or hemodynamic compromise;
  • symptomatic aortic stenosis;
  • uncontrolled symptomatic heart failure;
  • acute pulmonary embolus;
  • acute myocarditis or pericarditis;
  • suspected or known dissecting aneurism; or
  • coronary artery disease.
  • Functional impairment resulting in inability to exercise
  • Identified by patient as their primary caregiver
  • Age 18-80 years
  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Duke University Adult Bone Marrow Transplant Clinic

Durham, North Carolina, 27705, United States

Location

MeSH Terms

Conditions

Hematologic Neoplasms

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Results Point of Contact

Title
Dr. Anthony Sung
Organization
Duke University Medical Center

Study Officials

  • Anthony Sung, MD

    Duke Health

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 28, 2019

First Posted

January 30, 2019

Study Start

May 6, 2019

Primary Completion

October 27, 2022

Study Completion

April 27, 2024

Last Updated

September 27, 2024

Results First Posted

September 27, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations